Antibody-Drug Conjugate Tackles Glucocorticoid Use in PMR
A novel conjugate of adalimumab and a proprietary glucocorticoid receptor modulator for patients with PMR led to longer time to flare and fewer flares and reduced the glucocorticoid dose needed.
Medscape Medical News
source https://www.medscape.com/viewarticle/antibody-drug-conjugate-tackles-glucocorticoid-use-2025a10002ok?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/antibody-drug-conjugate-tackles-glucocorticoid-use-2025a10002ok?src=rss
Comments
Post a Comment